Subtopic Deep Dive

Abdominal Aortic Aneurysm Screening
Research Guide

What is Abdominal Aortic Aneurysm Screening?

Abdominal Aortic Aneurysm Screening involves ultrasound-based population screening programs, cost-effectiveness analyses, and risk stratification models to detect aneurysms and prevent rupture in at-risk groups like men aged 65-74.

Ultrasound screening targets high-risk populations such as older men to identify aneurysms ≥5.5 cm for surveillance or repair. Randomized trials like UKSAT and Danish studies demonstrate reduced aneurysm-related mortality (Norman, 2004; Lindholt et al., 2005). Over 10 key papers from 2004-2018, with ESC and ESVS guidelines citing screening efficacy (Erbel et al., 2014; Wanhainen et al., 2018).

15
Curated Papers
3
Key Challenges

Why It Matters

Screening programs reduce aneurysm rupture mortality by 40-50% in screened cohorts, guiding national policies like UK's NHS AAA program. Cost-effectiveness analyses support one-time ultrasound for men 65-75, saving lives and healthcare costs (Lindholt et al., 2005; Chaikof et al., 2009). Risk factor studies enable targeted screening, lowering prevalence detection burdens (Kent et al., 2010; Svensjö et al., 2011). ESVS guidelines recommend screening based on trial data, influencing global implementation (Wanhainen et al., 2018).

Key Research Challenges

Optimal Screening Age Selection

Trials show varying efficacy by age; Norman (2004) found no overall mortality benefit in men 65-83 due to broad targeting. Narrowing to 65-74 maximizes yield but misses subgroups (Lindholt et al., 2005). Balancing participation and ineligibility exclusion remains critical.

Declining AAA Prevalence

Swedish screening detected low 1.4% prevalence in 65-year-olds, questioning program viability (Svensjö et al., 2011). Epidemiological shifts from smoking decline alter risk profiles (Kent et al., 2010). Adjusting thresholds and frequencies challenges cost-effectiveness.

Risk Stratification Accuracy

Multifactor models predict growth but lack precision for individuals (Kent et al., 2010). Integrating biomarkers with diameter measurements is underexplored (Michel et al., 2010). Validating models across populations hinders personalized surveillance.

Essential Papers

1.

2014 ESC Guidelines on the diagnosis and treatment of aortic diseases

Authors Task Force Members, Raimund Erbel, Victor Aboyans et al. · 2014 · European Heart Journal · 4.3K citations

2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the D...

2.

Editor's Choice – European Society for Vascular Surgery (ESVS) 2019 Clinical Practice Guidelines on the Management of Abdominal Aorto-iliac Artery Aneurysms

Anders Wanhainen, Fabio Verzini, Isabelle Van Herzeele et al. · 2018 · European Journal of Vascular and Endovascular Surgery · 2.2K citations

3.

Editor's Choice – Management of Descending Thoracic Aorta Diseases

Vicente Riambau, D. Böckler, Jan Brunkwall et al. · 2017 · European Journal of Vascular and Endovascular Surgery · 1.2K citations

4.

The care of patients with an abdominal aortic aneurysm: The Society for Vascular Surgery practice guidelines

Elliot L. Chaikof, David C. Brewster, Ronald L. Dalman et al. · 2009 · Journal of Vascular Surgery · 714 citations

5.

Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals

K. Craig Kent, Robert M. Zwolak, Natalia Egorova et al. · 2010 · Journal of Vascular Surgery · 704 citations

6.

Population based randomised controlled trial on impact of screening on mortality from abdominal aortic aneurysm

Paul E. Norman · 2004 · BMJ · 511 citations

At a whole population level screening for abdominal aortic aneurysms was not effective in men aged 65-83 years and did not reduce overall death rates. The success of screening depends on choice of ...

7.

Endovascular or open repair strategy for ruptured abdominal aortic aneurysm: 30 day outcomes from IMPROVE randomised trial

Improve T. Investigators · 2014 · BMJ · 465 citations

Current Controlled Trials ISRCTN48334791.

Reading Guide

Foundational Papers

Start with Erbel et al. (2014) ESC Guidelines for diagnostic thresholds, then Chaikof et al. (2009) SVS guidelines for management algorithms, followed by Norman (2004) UKSAT RCT for mortality outcomes.

Recent Advances

Wanhainen et al. (2018) ESVS Guidelines update screening recommendations; Svensjö et al. (2011) analyzes prevalence decline impacting program design.

Core Methods

Ultrasound measures AP diameter; RCTs use ITT analysis for all-cause mortality; risk models employ logistic regression on cohort data (Kent et al., 2010).

How PapersFlow Helps You Research Abdominal Aortic Aneurysm Screening

Discover & Search

Research Agent uses searchPapers and exaSearch to find UKSAT trial follow-ups, then citationGraph on Norman (2004) reveals 500+ citing works on age-specific outcomes. findSimilarPapers expands to RESCAN studies from Lindholt et al. (2005).

Analyze & Verify

Analysis Agent applies readPaperContent to extract prevalence data from Svensjö et al. (2011), then runPythonAnalysis with pandas to meta-analyze rates across 5 trials. verifyResponse (CoVe) and GRADE grading assess evidence quality for screening recommendations (Erbel et al., 2014).

Synthesize & Write

Synthesis Agent detects gaps in cost-effectiveness post-2018 via contradiction flagging between Wanhainen et al. (2018) and older trials. Writing Agent uses latexEditText, latexSyncCitations for guideline summaries, and latexCompile for report export.

Use Cases

"Run meta-analysis of AAA screening mortality reduction across RCTs"

Research Agent → searchPapers('AAA screening RCT') → Analysis Agent → runPythonAnalysis(pandas meta-analysis on Norman 2004, Lindholt 2005) → CSV export of pooled RR 0.57 (95% CI 0.45-0.74).

"Draft LaTeX review on ESVS screening guidelines with citations"

Synthesis Agent → gap detection (Wanhainen 2018) → Writing Agent → latexEditText('screening section') → latexSyncCitations(10 papers) → latexCompile → PDF with flowchart.

"Find GitHub repos with AAA risk prediction models"

Research Agent → paperExtractUrls(Kent 2010) → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python scripts for Cox models from 3M cohort data.

Automated Workflows

Deep Research workflow conducts systematic review: searchPapers(50+ AAA screening) → DeepScan(7-step GRADE analysis) → structured report on mortality RRR. Theorizer generates hypotheses on prevalence decline from Svensjö (2011) + Kent (2010) risk factors. Chain-of-Verification verifies trial inconsistencies across Norman (2004) and Lindholt (2005).

Frequently Asked Questions

What is Abdominal Aortic Aneurysm Screening?

Ultrasound-based one-time screening for men aged 65-74 detects infrarenal aortic diameter ≥3.0 cm for surveillance or ≥5.5 cm for repair referral (Wanhainen et al., 2018).

What methods prove screening efficacy?

RCTs like Chichester (UKSAT) and Danish trials show 40-68% aneurysm mortality reduction; ultrasound specificity >99% (Norman, 2004; Lindholt et al., 2005).

What are key papers?

ESC Guidelines (Erbel et al., 2014; 4317 cites), ESVS Guidelines (Wanhainen et al., 2018; 2237 cites), SVS Guidelines (Chaikof et al., 2009; 714 cites).

What open problems exist?

Adapting to declining prevalence (Svensjö et al., 2011), women inclusion, and AI-enhanced risk models beyond diameter (Kent et al., 2010).

Research Aortic aneurysm repair treatments with AI

PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:

See how researchers in Health & Medicine use PapersFlow

Field-specific workflows, example queries, and use cases.

Health & Medicine Guide

Start Researching Abdominal Aortic Aneurysm Screening with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Medicine researchers